JERUSALEM and NEEDHAM, Massachusetts, December 10 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced that three substantial medical research project findings will be presented at the upcoming AARC (American Association for Respiratory Care) Congress in Anaheim, California. These studies confirm the clinical benefits of End-tidal CO2 (EtCO2) monitoring using Oridion Microstream(R) capnography technology and clearly show that capnography needs to be included in a hospital's respiratory monitoring strategy.
Proprietary EtCO2 monitoring solutions from Oridion can increase patient safety and improve patient outcomes utilizing information from the patient's respiratory system. Oridion has focused on providing a technology that provides the clinician with a simple and accurate assessment of a patient's ventilatory status which can provide an early prediction of events. A short summary of the studies from ASA and AARC are discussed below.
An Israel Institute of Technology - Technion study concluded that EtCO2 measurement contributes significantly to the prediction of events during pediatric and adult endoscopy procedures under general anesthesia and conscious sedation.
Two research studies, completed in cooperation between The Brigham and
Women's Hospital (Boston, MA) and The
The above medical research projects join four additional papers that were
presented in October 2008 at the ASA (American Society of Anesthesiologists)
Annual Meeting in Orlando, Florida. Among the studies released was a
comprehensive research paper focused on Oridion's latest major initiative
"IPI* - Integrated Pulmonary Index" conducted by physician/scientists from
Additional papers presented at ASA included a study from the Brigham & Women's Hospital in Boston showing that CO2 measurement using the Oridion CapnoBloc(TM) is an effective and accurate sampling method during upper gastrointestinal endoscopy. Another important study concluded that expert medical education and training can improve patient safety.
Furthermore, a study published in this month's issue of PEDIATRICS - The Official Journal of the American Academy of Pediatrics concluded that Microstream(R) capnography with its low flow rate made non-invasive capnography possible in the NICU. The study also showed that ETCO2, measured by Microstream(R) capnography has good correlation with PACO2, and is reliable in severe lung disease.
A full list of the medical publications can be found on the Oridion Website http://www.oridion.com/global/english/clinical_solutions/overview/ research.html
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream(R) capnography technology has become the standard of care in ventilation monitoring.
*IPI is pending FDA 510(k) clearance
Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.
Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.
For further Oridion information please contact: Gerry Feldman, President, Walter Tabachnik, Chief Financial Officer, Elena Gerberg, Investor Relations, e-mail: email@example.com website:http://www.oridion.com phone: +972-2-589-9159, address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel.
|SOURCE Oridion Systems Ltd.|
Copyright©2008 PR Newswire.
All rights reserved